(a) Schematic illustration of antibody-functionalized LM nanocapsules
for target tumour elimination. (b) A mouse with large tumours on its
left and right side back 7 days after tumour cell transplantation (day 7).
The tumour on the left side back is being irradiated with 785 nm
laser. (c) A mouse after 3 days of treatment (day 10) with
Anti-EGFR-Biotin-Avidin-DSPE-PEG2000-Amine-DC(8,9)PC-LM and
laser irradiation of the tumour on its left side back. (d) Relative
volumes of tumours on the laser-induced left side back. HEPES dispersions of
Anti-EGFR-Biotin-Avidin-DSPE-PEG2000-Amine-DC(8,9)PC-LM (red
bars) or HEPES dispersions of
Avidin-DSPE-PEG2000-Amine-DC(8,9)PC-LM (blue bars), or HEPES
(black bars) were intratumourally injected and treated with
785 nm laser. Red, blue, and black arrows represent laser
irradiation periods for HEPES dispersions of
Anti-EGFR-Biotin-Avidin-DSPE-PEG2000-Amine-DC(8,9)PC-LM-,
HEPES dispersions of Avidin-DSPE-PEG2000-Amine-DC(8,9)PC-LM-, and
HEPES-injected mice, respectively. *N.D.: not determined because
tumours were completely disappeared. Error bars represent s.d.'s of
measurements from three mice. aP<0.005;
bP<0.05;
cP<0.5; dP<0.0005.
(e) Relative volume of tumours on the right side back that were
injected HEPES dispersions of
Anti-EGFR-Biotin-Avidin-DSPE-PEG2000-Amine-DC(8,9)PC-LM (red
bars) or HEPES dispersions of
Avidin-DSPE-PEG2000-Amine-DC(8,9)PC-LM (blue bars), or HEPES
(black bars) but not subjected to laser irradiation. Error bars represent
s.d.'s of measurements from three mice.
aP<0.5; bP<0.005;
cP<0.05.